Navigation Links
Takeda and Zinfandel Pharmaceuticals Initiate Phase 3 TOMMORROW Trial of AD-4833 for the Delay of Onset of Mild Cognitive Impairment Due to Alzheimer's Disease in Subjects Selected Using a Genetic-Based Biomarker Risk Assignment Algorithm
Date:8/26/2013

OSAKA, Japan and DURHAM, N.C., Aug. 26, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited ("Takeda") and its partner, Zinfandel Pharmaceuticals, Inc. ("Zinfandel"), today announced the initiation of TOMMORROW, a global Phase 3 clinical trial investigating a genetic-based biomarker risk assignment algorithm (risk assignment algorithm) to predict risk of mild cognitive impairment (MCI) due to Alzheimer's disease (AD) within a five year period and to evaluate the efficacy of the investigational low dose pioglitazone (designated AD-4833 for this use) in delaying the onset of MCI due to AD in cognitively normal individuals at high risk as determined by the risk assignment algorithm.

The risk assignment algorithm is comprised of apolipoprotein E (APOE) and TOMM40 genotypes and age. Age and APOE genotype have previously been shown to indicate elevated risk of AD. The addition of TOMM40 is hypothesized to further refine the risk determination.

"To date, there have been a number of avenues investigated with the goal of altering the course of Alzheimer's disease but results have been unsuccessful," said Allen Roses, M.D., Chief Executive Officer, Zinfandel. "This is why the TOMMORROW trial is important. The potential to identify an individual's risk for developing MCI due to AD warrants further investigation."

AD is a devastating disease and diagnoses are increasing as the world's population ages. Currently 35.6 million people worldwide are living with some form of dementia. Studies show that individuals with MCI are at an increased risk of developing AD or another dementia with conversion rates of approximately 15 percent per year.

"AD-4833 is a member of a class of drugs known as PPAR (peroxisome proliferator-activated receptor)-gamma agonists which available data show may have a beneficial role in delaying symptoms of MCI due to AD," noted '/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Takeda Launches New Subsidiary in Peru
2. Data Published in the New England Journal of Medicine for Vedolizumab, an Investigational New Drug from Takeda for Moderately to Severely Active Ulcerative Colitis and Crohns Disease
3. Among New Agents Entering the Unipolar Depression Market Over the Next Decade, Lundbeck/Takeda Pharmaceuticals Brintellix Has Blockbuster Potential
4. Takeda Submits Biologics License Application for a New Investigational Drug Vedolizumab, in Moderately to Severely Active Crohns Disease and Ulcerative Colitis in the United States
5. Takeda Type 2 Diabetes Therapies, NESINA (alogliptin) and Fixed-Dose Combinations KAZANO (alogliptin and metformin HCl) and OSENI (alogliptin and pioglitazone), Are Now Available in Pharmacies in the United States
6. AGA Research Foundation Announces Endowment Gift from Takeda Pharmaceuticals U.S.A., Inc. to Support Gastroenterology Research
7. Takeda to Acquire Inviragen, Inc.
8. Takeda Responds to Verdict in Diabetes Drug Case
9. Takeda Launches New Subsidiary in Ecuador
10. Takeda lanza nueva subsidiaria en Ecuador
11. Scripps Research Institute and Takeda Pharmaceuticals Announce Expanded Research Collaboration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... This September leading clinicians in orthodontics and ... for DOCtalk 2014 —a "Dynamic Orthodontic ... and private practitioner Dr. David Sarver , DOCtalk ... clinical and practice management efficiency and high quality patient ... to welcome fresh thinking and join a community of ...
(Date:7/23/2014)... 2014  Cardica, Inc. (Nasdaq: CRDC ) today ... fourth quarter and year ended June 30, 2014, on Thursday, ... host a conference call at 4:30 p.m. Eastern Time to ... company,s business. Conference Call Details To access the ... Eastern Time via phone, please dial 866-953-6859 from ...
(Date:7/23/2014)... , July 23, 2014  Silk Road ... the transcarotid treatment of intra- and extra-cranial cerebrovascular ... P. Wallace to the position of Chief ... lead the company,s Research and Development efforts across ... Prior to joining Silk Road ...
Breaking Medicine Technology:2014 DOCtalk Registration Now Open 22014 DOCtalk Registration Now Open 3Cardica to Announce Fiscal 2014 Fourth Quarter and Full Year Financial Results on Thursday, August 7, 2014 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3
... Mass., Jan. 17, 2012 /PRNewswire-iReach/ -- Liberty ... Advanced training program for distributor packaging representatives. The program ... at the manufacturing industry " Do You Know What ... commented: "The Intercept Technology heavy duty barrier packaging is ...
... AUSTIN, Texas, Jan. 17, 2012   SpineSmith , a ... technologies in the field of regenerative medicine, is pleased to ... of PhDs. Dr. Murphy joins SpineSmith in ... new strategies for the isolation and application of autologous stem ...
Cached Medicine Technology:Intercept Technology Packaging Advanced Training Program Hosted by Liberty Packaging 2SpineSmith Adds Talented Scientist to Research and Development Team 2
(Date:7/23/2014)... 2014 Researchers in Turkey say a ... yellow pigment in the spice turmeric, and an immunosuppressor ... lab. To read the full story on Surviving ... University in Ankara, Turkey pretreated mesothelioma cells ... them to two platinum-based chemotherapy drugs with promising results. ...
(Date:7/23/2014)... 23, 2014 Low enrollment and ... exchanges to come up with alternative means to ... myriad ways to accomplish this in the July ... Insurance Exchanges (HEX). , “We never expected the ... exchanges, Christopher Condeluci, an attorney at the law ...
(Date:7/23/2014)... 23, 2014 On July 19 and 20, ... the NBC 4 New York and New York Giants Health ... NJ. , The team, which included several hearing ... offered free hearing health screenings and answered any questions that ... hearing technology. , Also sponsored by the NFL Players ...
(Date:7/23/2014)... There is inherently nothing wrong with sweating. ... healthy enough to react to specific changes in the ... toxins and bacteria from the body in ways that ... do. , However, the social implications for people ... “excessive sweating”—are serious: since sweating itself often causes instances ...
(Date:7/23/2014)... Townsend Security, a leading authority in ... i security solutions now support two factor authentication. This ... of relying on passwords as their only authentication mechanism. ... Alliance Two Factor Authentication software with the following ... Alliance AES/400 – High performance, NIST validated AES ...
Breaking Medicine News(10 mins):Health News:New Research Finds Pretreatment of Mesothelioma Cells with These Two Compounds Boosts Chemotherapy Response, According to Surviving Mesothelioma 2Health News:New Research Finds Pretreatment of Mesothelioma Cells with These Two Compounds Boosts Chemotherapy Response, According to Surviving Mesothelioma 3Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 2Health News:Industry Observers Tell AIS They Predict Changes to Exchange User Fees, Platforms 3Health News:The HearStrong Foundation Provides Hearing Healthcare Awareness at the NBC 4 New York and New York Giants Health & Fitness Expo 2014 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 2Health News:Beat Your Sweating Demons Review | The Problem With Excessive Sweating and Solving it Naturally – Vinamy.com 3Health News:Townsend Security Brings Two Factor Authentication to Leading IBM i Security Solutions 2
... Lyerly, M.D., director of the Duke Comprehensive Cancer Center, has been ... , Lyerly was one of eight appointees named to the board ... an advisory committee of the U.S. National Cancer Institute (NCI). ... the Department of Health and Human Services and the director ...
... June 16 Align,Technology, Inc. (Nasdaq: ... the Company,s,Aligntechinstitute.com has received the Gold ... from the Healthcare Communications,Marketing Association (HCMA). ... Invisalign product support, instructor-led and,web-based continuing ...
... Officeinacar is debuting its,new Deskinacar. Deskinacar is a ... can be stowed in most 17" laptop bags., ... for the,businessperson on the move, whether traveling in and ... wherever immediate desk space is,needed., "As an insurance ...
... and drug misuse mean Scots are almost twice as ... to people living in England and Wales, research published ... The University of Manchester,s National Confidential Inquiry into Suicide ... show that the number of mental health patients committing ...
... Bandana, Dog Owners Get an Opportunity to ... DENVER, June 16 Camp Bow Wow, the ... launched a fund raising,effort on behalf of Morris Animal ... dog cancer,and fight other major dog diseases. Beginning June ...
... Campers Get a Campaign Bandana, Dog Owners Get an ... Cancer and other Diseases, DENVER, June 16 ... and overnight camp, has launched a fund raising,effort on ... its campaign to cure dog cancer,and fight other major ...
Cached Medicine News:Health News:Aligntechinstitute.com Wins International Award of Excellence From Healthcare Communications Marketing Association 2Health News:Aligntechinstitute.com Wins International Award of Excellence From Healthcare Communications Marketing Association 3Health News:Officeinacar Introduces Deskinacar - The Truly 'Portable' Car Desk: the Lightweight Solution to a Businessperson's Travel Office Needs 2Health News:Drink and drugs fuel Scottish suicide and homicide rates 2Health News:Drink and drugs fuel Scottish suicide and homicide rates 3Health News:Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundation's Canine Cancer Campaign - Dogs Get Bandanas; Camp Bow Wow Locations in New Jersey Participating 2Health News:Camp Bow Wow(R) Launches Fundraising Effort to Help Cure Cancer in Dogs, via Morris Animal Foundation's Canine Cancer Campaign - Dogs Get Bandanas 2
... the most efficient,aspiration is achieved ... of the,cannula tip. Rigorous engineering,incorporated ... II Reciprocating Cannula,assures that the ... to a longitudinal axis to,maintain ...
Inquire...
... The VASER System represents a major ... technology to cosmetic procedures. Combined with ... tissue emulsification, a solid grooved probe ... VASER System has been designed to ...
... generation of the ultra-quiet PSI-TEC ... retains all the smooth, reliable,performance ... leading name for,aspiration surgery worldwide. ... for high powered operation, the ...
Medicine Products: